Issue 97, 2019

Thermoresponsive drug delivery to mitochondria in vivo

Abstract

Mitochondrial targeting of drugs largely relies on delocalized lipophilic cations. Nevertheless, mitochondrial membrane potentials in cancer cells are inconstant, which could compromise stable mitochondrial targeting. Herein, we further validated a mitochondrial temperature-dependent drug delivery strategy in vivo. Thermoresponsive drug delivery to mitochondria may represent a promising strategy for cancer therapy.

Graphical abstract: Thermoresponsive drug delivery to mitochondria in vivo

Supplementary files

Article information

Article type
Communication
Submitted
25 Sep 2019
Accepted
11 Nov 2019
First published
11 Nov 2019

Chem. Commun., 2019,55, 14645-14648

Thermoresponsive drug delivery to mitochondria in vivo

L. Ruan, M. Zhou, J. Chen, H. Huang, J. Zhang, H. Sun, Z. Chai and Y. Hu, Chem. Commun., 2019, 55, 14645 DOI: 10.1039/C9CC07538K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements